Two studies concerning post-licensure use of the meningococcal group B vaccine published today in the New England Journal of Medicine show the vaccine prevents disease among recipients, but it does not affect pharyngeal carriage of the bacterium Neisseria meningitidis on a population level.
The studies are based on data collected from the United Kingdom and Australia.
Filling in previous data gaps
Jan 23 N Engl J Med UK study
Jan 23 N Engl J Med Australia study
Jan 23 N Engl J Med commentary
Jan 23 PHE press release
Jan 22 University of Adelaide press release